Evidence map›Paper›PMID 25485900›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2015

Overexpression of adenylyl cyclase type 5 (AC5) confers a proarrhythmic substrate to the heart.

Zhenghang Zhao, Gopal J Babu, Hairuo Wen, Nadezhda Fefelova, Richard Gordan, Xiangzhen Sui, Lin Yan, Dorothy E Vatner, Stephen F Vatner, Lai-Hua Xie

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Annexin A4 Deficient Ventricular Myocytes Display Advanced Hypertrophy and Electrical Remodeling With Chronic β-Adrenoceptor Stimulation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. p22Nature cardiovascular research · 2025
    Article
  4. Article
  5. Article
  6. In Vivo Cardiac-specific Expression of Adenylyl Cyclase 4 Gene Protects against Klotho Deficiency-induced Heart Failure.Translational research : the journal of laboratory and clinical medicine · 2022
    Article
  7. Article
  8. Calcium and Heart Failure: How Did We Get Here and Where Are We Going?International journal of molecular sciences · 2021
    Review
  9. Proteomic analysis of mitochondrial biogenesis in cardiomyocytes differentiated from human induced pluripotent stem cells.American journal of physiology. Regulatory, integrative and comparative physiology · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Antioxidant defense and protection against cardiac arrhythmias: lessons from a mammalian hibernator (the woodchuck).FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Zhenghang ZhaoDepartment of Pharmacology, School of Medicine, Xi'an Jiaotong University, Xi'an, People's Republic of China; Department of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, New Jersey;
Gopal J BabuDepartment of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, New Jersey;
Hairuo WenDepartment of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, New Jersey; Department of Reproductive and Genetic Toxicology, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing, People's Republic of China; and.
Nadezhda FefelovaDepartment of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, New Jersey;
Richard GordanDepartment of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, New Jersey;
Xiangzhen SuiDepartment of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, New Jersey;
Lin YanDepartment of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, New Jersey;
Dorothy E VatnerDepartment of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, New Jersey;
Stephen F VatnerDepartment of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, New Jersey;
Lai-Hua XieDepartment of Cell Biology and Molecular Medicine, Rutgers University-New Jersey Medical School, Newark, New Jersey; School of Pharmacology, Xinxiang Medical University, Xixiang, People's Republic of China xiela@njms.rutgers.edu.
Rutgers New Jersey Medical SchoolRutgers, The State University of New Jersey · USNational Institutes for Food and Drug Control · CNXi'an Jiaotong University · CNXinxiang Medical University · CN

Funding

Molecular Mechanisms in Chronically Stunned MyocardiumP01HL069020 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, DOROTHY EILEEN · 2001 to 2014
$21.3M
Longevity and Stress ResistanceP01AG027211 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2007 to 2013
$10.3M
CARDIOVASCULAR CONTROL IN NORMAL AND DISEASE STATESR01HL033107 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 1985 to 2011
$6.2M
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KOR01HL106511 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2011 to 2019
$3.8M
Integrative Mechanisms in Cardiovascular DiseaseT32HL069752 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2004 to 2013
$2.9M
Intrinsic Vascular Smooth Muscle Cell StiffnessR01HL102472 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2010 to 2016
$2.5M
Adenylyl cyclase isoforms in hypertrophy and heart failureR01HL093481 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2009 to 2013
$2.3M
Antiarrhythmic Mechanisms in the Hearts of Hibernating MammalsR01HL097979 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI XIE, LAI-HUA · 2010 to 2015
$1.9M
SFRP2, cell survival, and coronary vascular angiogenesisR01HL119464 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI VATNER, DOROTHY EILEEN · 2013 to 2016
$1.8M
Rescue of Beta-Adrenergic Cardiomyopathy by Inhibition of Adenylyl CyclaseR01HL095888 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, DOROTHY EILEEN · 2009 to 2014
$1.7M
Mechanisms of Intrinsic Cardioprotection in Marmota momaxR01HL091781 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI YAN, LIN · 2008 to 2011
$1.6M
Gender Differences in Caloric Restriction CardioprotectionR21HL097264 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI YAN, LIN · 2009 to 2010
$429k
NHLBI NIH HHS 1R01-HL-102472NHLBI NIH HHS 1R01-HL-119464NHLBI NIH HHS 5P01-HL-069020NHLBI NIH HHS 5R01-HL-033107NHLBI NIH HHS 5R01-HL-091781NHLBI NIH HHS 5R01-HL-095888NHLBI NIH HHS 5R21-HL-097264NHLBI NIH HHS 5T32-HL-069752NHLBI NIH HHS R01 HL093481NHLBI NIH HHS R01-HL-093481NHLBI NIH HHS R01 HL097979NHLBI NIH HHS R01 HL102472NHLBI NIH HHS R01 HL106511NHLBI NIH HHS R01-HL-106511NHLBI NIH HHS R01 HL119464NHLBI NIH HHS R01-HL-97979NIA NIH HHS 5P01-AG-027211
6 · The paper itself

Abstract

Inhibition of β-adrenergic receptor (β-AR) signaling is one of the most common therapeutic approaches for patients with arrhythmias. Adenylyl cyclase (AC) is the key enzyme responsible for transducing β-AR stimulation to increases in cAMP. The two major AC isoforms in the heart are types 5 and 6. Therefore, it is surprising that prior studies on overexpression of AC5 and AC6 in transgenic (Tg) mice have not examined mediation of arrhythmogenesis. Our goal was to examine the proarrhythmic substrate in AC5Tg hearts. Intracellular calcium ion (Ca(2+) i) was imaged in fluo-4 AM-loaded ventricular myocytes. The sarcoplasmic reticulum (SR) Ca(2+) content, fractional Ca(2+) release, and twitch Ca(2+) transient were significantly higher in the AC5Tg vs. wild-type (WT) myocytes, indicating Ca(2+) overload in AC5Tg myocytes. Action potential (AP) duration was significantly longer in AC5Tg than in WT myocytes. Additionally, AC5Tg myocytes developed spontaneous Ca(2+) waves in a larger fraction compared with WT myocytes, particularly when cells were exposed to isoproterenol. The Ca(2+) waves further induced afterdepolarizations and triggered APs. AC5Tg hearts had increased level of SERCA2a, oxidized Ca(2+)/calmodulin-dependent protein kinase II (CaMKII), and phosphorylation of ryanodine receptors (RyR) at the CaMKII site, especially after isoproterenol treatment. This was consistent with higher reactive oxygen species production in AC5Tg myocytes after isoproterenol treatment. Isoproterenol induced more severe arrhythmias in AC5Tg than in WT mice. We conclude that AC5 overexpression promotes arrhythmogenesis, by inducing SR Ca(2+) overload and hyperactivation of RyR (phosphorylation by CaMKII), which in turn induces spontaneous Ca(2+) waves and afterdepolarizations.

Indexed as

Action PotentialsAdenylyl CyclasesAnimalsArrhythmias, CardiacCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium SignalingCardiotonic AgentsCells, CulturedHeart VentriclesIsoenzymesIsoproterenolMiceMyocytes, CardiacReactive Oxygen SpeciesRyanodine Receptor Calcium Release ChannelAdenylyl CyclasesCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Cardiotonic AgentsIsoenzymesIsoproterenolReactive Oxygen SpeciesRyanodine Receptor Calcium Release ChannelSarcoplasmic Reticulum Calcium-Transporting ATPasesadenylyl cyclase type 5arrhythmiascalcium handlingelectrophysiologyoverexpression

Identifiers

PMID25485900
PMCPMC4312946
OpenAlexW2101538331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.